Literature DB >> 28804907

Allergic contact dermatitis caused by isobornyl acrylate in Freestyle® Libre, a newly introduced glucose sensor.

Anne Herman1, Olivier Aerts2, Marie Baeck1, Magnus Bruze3, Christophe De Block4, An Goossens5, Nils Hamnerius3, Sara Huygens5, Dominique Maiter6, Dominique Tennstedt1, Bernard Vandeleene6, Martin Mowitz3.   

Abstract

BACKGROUND: Glucose sensors, such as FreeStyle® Libre, are innovative medical devices developed for diabetes patients as a replacement for classic glucose meters, ensuring continuous glucose monitoring without the disadvantage of regular skin finger pricks.
OBJECTIVES: To report several cases of allergic contact dermatitis caused by FreeStyle® Libre, and to report on isobornyl acrylate as a culprit allergen. PATIENTS AND METHODS: Fifteen patients presented with allergic contact dermatitis caused by FreeStyle® Libre. All but 1 were patch tested with a baseline series, and with pieces and/or ultrasonic bath extracts of (the adhesive part of) the glucose sensor. Isobornyl acrylate was patch tested, in various concentrations and vehicles, in 13 patients. Gas chromatography-mass spectrometry (GC-MS) of the sensors was performed.
RESULTS: All patients reacted to the adhesive part of the sensor, and 12 patients were shown to be sensitized to isobornyl acrylate. Simultaneous reactions to other allergens were rarely observed. GC-MS showed the presence of isobornyl acrylate in the sensors.
CONCLUSIONS: Cases of allergic contact dermatitis caused by FreeStyle® Libre are increasingly being observed, and isobornyl acrylate is a relevant culprit allergen. Cross-reactivity to other acrylates was infrequently observed, but other, hitherto unidentified, contact allergens may still be present in the device.
© 2017 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  CAS no. 5888-33-5; FreeStyle® Libre; acrylates; adhesive; allergic contact dermatitis; diabetes mellitus; gas chromatography; glucose sensor; isobornyl acrylate; mass spectrometry; medical device; sesquiterpene lactone mix

Mesh:

Substances:

Year:  2017        PMID: 28804907     DOI: 10.1111/cod.12866

Source DB:  PubMed          Journal:  Contact Dermatitis        ISSN: 0105-1873            Impact factor:   6.600


  23 in total

1.  Five-Month Follow-up Shows No Improvement in Dermatological Complications in Children With Type 1 Diabetes Using Continuous Glucose Monitoring Systems and Insulin Pumps.

Authors:  Anna T Weng; Claus Zachariae; Karl B Christensen; Jannet Svensson; Anna K Berg
Journal:  J Diabetes Sci Technol       Date:  2019-10-16

Review 2.  Positioning time in range in diabetes management.

Authors:  Andrew Advani
Journal:  Diabetologia       Date:  2019-11-07       Impact factor: 10.122

3.  Cutaneous Reactions to Continuous Glucose Monitoring and Continuous Subcutaneous Insulin Infusion Devices in Type 1 Diabetes Mellitus.

Authors:  Rachel S Rigo; Laura E Levin; Donald V Belsito; Maria C Garzon; Rachelle Gandica; Kristen M Williams
Journal:  J Diabetes Sci Technol       Date:  2020-05-09

4.  Cutaneous Complications With Continuous or Flash Glucose Monitoring Use: Systematic Review of Trials and Observational Studies.

Authors:  Nurul A Mohd Asarani; Andrew N Reynolds; Sara E Boucher; Martin de Bock; Benjamin J Wheeler
Journal:  J Diabetes Sci Technol       Date:  2019-08-27

5.  Preserving Skin Integrity with Chronic Device Use in Diabetes.

Authors:  Laurel H Messer; Cari Berget; Christie Beatson; Sarit Polsky; Gregory P Forlenza
Journal:  Diabetes Technol Ther       Date:  2018-06       Impact factor: 6.118

6.  Further Evidence of Severe Allergic Contact Dermatitis From Isobornyl Acrylate While Using a Continuous Glucose Monitoring System.

Authors:  Stefanie Kamann; Olivier Aerts; Lutz Heinemann
Journal:  J Diabetes Sci Technol       Date:  2018-03-15

7.  Manufacturing Process Changes and Reduced Skin Irritations of an Adhesive Patch Used for Continuous Glucose Monitoring Devices.

Authors:  Vitaliy Gisin; Anna Chan; John B Welsh
Journal:  J Diabetes Sci Technol       Date:  2017-10-27

Review 8.  [Contact allergy due to insulin pumps and glucose sensor systems].

Authors:  N Wagner; S Kamann; E Oppel
Journal:  Hautarzt       Date:  2020-03       Impact factor: 0.751

9.  Extraction With Sweat-Sebum Emulsion as a New Test Method for Leachables in Patch-Based Medical Devices, Illustrated by Assessment of Isobornylacrylate (IBOA) in Diabetes Products.

Authors:  Herbert Fink; Nuno M de Barros Fernandes; Jörg Weissmann; Manfred Frey
Journal:  J Diabetes Sci Technol       Date:  2020-03-01

10.  In Response to the Letter to the Editor on Minimizing Adverse Skin Reactions to Wearable Continuous Glucose Monitoring Sensors.

Authors:  Martin Mowitz; Josefin Ulriksdotter; Magnus Bruze; Cecilia Svedman
Journal:  J Diabetes Sci Technol       Date:  2021-04-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.